Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
CV Sciences, Inc. (CVSI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Second Quarter 2023 Financial Results"
06/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CV Sciences, Inc. 2023 EQUITY INCENTIVE PLAN Plan Adopted by the Board: April 11, 2023 Plan Approved by the Shareholders: June 1, 2023"
05/15/2023 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports First Quarter 2023 Financial Results"
03/29/2023 8-K Quarterly results
03/02/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 2 of 51 Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 3 of 51 Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 4 of 51",
"TO: ALL PERSONS WHO OWNED CANNAVEST CORP., NOW KNOWN AS CV SCIENCES, INC.",
"CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation"
11/14/2022 8-K Quarterly results
10/25/2022 8-K Quarterly results
09/27/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"ORDER PRELIMINARILY APPROVING SETTLEMENT AND PROVIDING FOR NOTICE 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"NOTICE OF PROPOSED SETTLEMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation"
08/15/2022 8-K Quarterly results
07/27/2022 8-K Resignation/termination of a director
06/06/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results"
03/28/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CV SCIENCES, INC. TO SECOND SUPPLEMENTAL INDENTURE TO INDENTURE DATED NOVEMBER 17, 2021",
"12544 High Bluff Drive"
12/21/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXECUTIVE EMPLOYMENT AGREEMENT"
11/30/2021 8-K Auditor change
Docs: "CV Sciences, Inc. Appoints Haskell & White LLP as Auditor"
11/15/2021 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Third Quarter 2021 Financial Results"
09/30/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/13/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Second Quarter 2021 Financial Results"
07/30/2021 8-K Quarterly results
06/29/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/18/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Third Quarter 2020 Financial Results San Diego, CA - November 5, 2020 - CV Sciences, Inc. , a preeminent supplier and manufacturer of hemp cannabidiol products, today announced its financial results for the quarter ended September 30, 2020. Third Quarter 2020 and Recent Operating Highlights"
08/06/2020 8-K Quarterly results
07/31/2020 8-K Quarterly results
06/19/2020 8-K Quarterly results
05/20/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "CV SCIENCES, INC. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020 SAN DIEGO, May 20, 2020 -- CV Sciences, Inc. , a preeminent supplier and manufacturer of hemp cannabidiol products, today announced that it will adjourn its 2020 Annual Meeting of Stockholders to June 16, 2020 in order to allow additional time to solicit proxies as a result of mailing difficulties faced by the Company’s proxy solicitation firm relating to the COVID-19 pandemic. To implement this change, the 2020 Annual Meeting of Stockholders will be convened on May 21, 2020 at 10:00 a.m. Pacific Time and immediately adjourned to June 16, 2020. No business will be conducted at the meeting on May 21, 2020 other than to adjourn the meeting to a later date. The Annual Meeting will be reconvened and hel..."
05/08/2020 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports First Quarter 2020 Financial Results San Diego, CA - May 8, 2020 - CV Sciences, Inc. , a preeminent supplier and manufacturer of hemp cannabidiol products, today announced its financial results for the quarter ended March 31, 2020. First Quarter 2020 and Recent Operating Highlights"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy